GlassScriptPhysician profile
David J Beachum
NPI 1881244259
$1,168.15
in general payments reported to CMS, 2019-2025
18 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.44 · 2023: $194 · 2024: $446 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $256.87 | 2024-2025 | Rystiggo, Nayzilam, Zilbrysq |
| Biogen, INC. | $243.73 | 2023-2025 | Vumerity, Skyclarys, Skyclarys |
| Alexion Pharmaceuticals, INC. | $166.45 | 2023-2024 | Ultomiris, Soliris |
| Otsuka America Pharmaceutical, INC. | $96.09 | 2023-2025 | Rexulti, Nuedexta |
| Amneal Pharmaceuticals LLC | $58.60 | 2024 | Rytary, Ongentys |
| Eisai INC. | $56.03 | 2023-2025 | |
| Sk Life Science, INC. | $45.48 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $38.50 | 2025 | Austedo Xr, Ajovy |
| Genentech USA, INC. | $36.10 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Pacira Pharmaceuticals Incorporated | $23.72 | 2024 | Exparel |
| Astrazeneca Pharmaceuticals LP | $23.52 | 2023 | Andexxa |
| Biohaven Pharmaceutical Holding Company LTD. | $19.66 | 2022 | |
| Amgen INC. | $19.03 | 2025 | Uplizna |
| Harmony Biosciences LLC | $18.72 | 2025 | |
| Pfizer INC. | $17.73 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $17.07 | 2025 | Zeposia |
| Abbvie INC. | $16.55 | 2023 | |
| Emd Serono, INC. | $14.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beachum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.